Everyone

Bayer AG

Lollipop

myBETAapp™ is designed to assist you with managing your injections. myBETAapp™ shall only be used by patients which are at least 18 years old and have been prescribed the basic therapeutic drug from Bayer for the treatment of multiple sclerosis. It provides you with tools to record injection information either manually entered or automatically by connecting with the corresponding autoinjector.

myBETAapp™ includes the following features and functions:
1. Display scheduled injections according to the injection routine, i.e., one injection every other day.
2. Display recommended injection sites on the body, based on the recommended injection site rotation (injection sites are based on the standard rotation scheme). 
3. Display a monthly calendar of scheduled and recorded injections.
4. Connect the autoinjector via Bluetooth and transfer injection data recorded with the autoinjector.
5. Send reminders to you.
6. Record indicators of health and wellness and summarize the information in a chart. (This feature is not available in all countries.)
7. Allow you to share your information, including details of your injections, with your nurse or healthcare professional if you opt to do so. (This feature is not available in all countries.)
8. Receive messages from your nurse if you wish to do so. (This feature is not available in all countries.)

The reminder is not synchronized with the reminder used in the autoinjector. You may get reminders from both your autoinjector and from myBETAapp™ at different times. Make sure that you only take your medication as prescribed by your physician.

Bayer values your comments, questions and concerns posted on the App Store. As responding within the App Store is limited please contact us directly at 00800-22937-024 (00800-BAYER0AG). Please note that we will not provide any information about products. In case of questions regarding our products please contact your physician or pharmacist. If you are experiencing a medical emergency, contact your healthcare professional immediately.

myBETAapp™ is not intended to offer or replace professional medical advice. If you have any questions regarding your MS-treatment please contact your physician.

BAYER, the Bayer Cross and myBETAapp are trademarks of Bayer.

L.IE.MKT.04.2017.1187
L.CH.MKT.05.2017.0047-DE/EN/FR/IT
myBETAapp™旨在帮助您管理注射。 myBETAapp™只应由患者，其在年满18岁，并已规定从拜耳的基本治疗药物为多发性硬化症的治疗。它为您提供的工具来记录注射信息手动输入或通过与相应的自动进样器自动连接。

myBETAapp™包括以下特征和功能：
根据注射例程1.显示预定注射剂，即，每隔一天注射一次。
2.显示建议的身体注射部位，基于所述推荐注射部位的旋转（注射位点是基于标准循环方案）。
3.显示预定并记录注射的月历。
4.通过蓝牙自动注射器连接和传输记录有自动注射器注入数据。
5.发送提醒你。
6.健康和保健和记录指标汇总的图表中的信息。 （此功能并非在所有国家提供。）
7.让你分享你的信息，包括您的注射详细情况，请护士或医疗专业人士，如果你选择这样做。 （此功能并非在所有国家提供。）
8.从你的护士接收信息，如果你想这样做。 （此功能并非在所有国家提供。）

提醒不与自我注射器中使用的催同步。您可能会收到来自您的自动进样器，并从myBETAapp™在不同的时间提醒。请确保你的，只有你的医生规定把你的药。

拜耳非常重视您的意见，问题并张贴在App Store上的关注。由于在App Store内响应仅限请直接00800-22937-024（00800-BAYER0AG）与我们联系。请注意，我们将不提供关于产品的任何信息。在对我们的产品有疑问的情况下请咨询医师或药师。如果遇到紧急医疗情况，请立即与医疗专业人士。

myBETAapp™不打算提供或更换专业的医疗咨询。如果您对MS-处理有任何疑问，请联系您的医生。

拜耳，拜耳十字和myBETAapp是拜耳公司的商标。

L.IE.MKT.04.2017.1187
L.CH.MKT.05.2017.0047-DE / EN / FR / IT


myBETAapp™

myBETAapp™的最新版本

其他版本